Lista de obras - Nick Dand - Dominio Público Uruguay

An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target. ⬇️

artículo científico publicado en 2017

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

artículo científico publicado en 2021

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis

artículo científico publicado en 2019

BioGranat-IG: a network analysis tool to suggest mechanisms of genetic heterogeneity from exome-sequencing data.

artículo científico publicado en 2013

Clinical and genetic differences between pustular psoriasis subtypes

artículo científico publicado en 2018

Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk ⬇️

scientific article published on 01 October 2019

Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis ⬇️

artículo científico publicado en 2017

Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study ⬇️

scientific article published on 18 August 2018

Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis

artículo científico publicado en 2021

Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling

artículo científico publicado en 2017

Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis

artículo científico publicado en 2015

Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02

artículo científico publicado en 2019

Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne

artículo científico publicado en 2018

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

artículo científico publicado en 2018

Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants

artículo científico publicado en 2017

Network-Informed Gene Ranking Tackles Genetic Heterogeneity in Exome-Sequencing Studies of Monogenic Disease

artículo científico publicado en 2015

Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression

scientific article published on 09 November 2019

Psoriasis and Genetics

scientific article published on 30 January 2020

Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)

scientific article published on 08 July 2019

Text-mined phenotype annotation and vector-based similarity to improve identification of similar phenotypes and causative genes in monogenic disease patients

artículo científico publicado en 2018

Lista de obras de Nick Dand

An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target. ⬇️

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis

BioGranat-IG: a network analysis tool to suggest mechanisms of genetic heterogeneity from exome-sequencing data.

Clinical and genetic differences between pustular psoriasis subtypes

Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk ⬇️

Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis ⬇️

Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study ⬇️

Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis

Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling

Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis

Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02

Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants

Network-Informed Gene Ranking Tackles Genetic Heterogeneity in Exome-Sequencing Studies of Monogenic Disease

Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression

Psoriasis and Genetics

Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)

Text-mined phenotype annotation and vector-based similarity to improve identification of similar phenotypes and causative genes in monogenic disease patients